AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Recurrent Epithelial Ovarian Cancer

Combination Therapy for Recurrent Ovarian Cancer NCT05610735Phase 1, Phase 21 site๐Ÿ“ Louisville Sham Sunder Kakar ยท Tests: DOXIL, Withaferin A, Ashwagandha, Combination of ASWD and DOXIL MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site๐Ÿ“ Scottsdale Mayo Clinic ยท Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients NCT06522828Phase 21 site๐Ÿ“ Chongqing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ยท Tests: SSGJ-707, carboplatin, paclitaxel A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) NCT06023862Phase 227 sites๐Ÿ“ Clayton๐Ÿ“ Waratah๐Ÿ“ Melbourne Yonsei University ยท Tests: Dostarlimab, Bevacizumab, Doxorubicin, Gemcitabine, Paclitaxel A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB NCT06781151n/a2 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Sun Yat-sen University A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites๐Ÿ“ New Haven๐Ÿ“ Louisville๐Ÿ“ Shreveport Merck Sharp & Dohme LLC ยท Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites๐Ÿ“ Denver๐Ÿ“ Chicago๐Ÿ“ Grand Rapids Context Therapeutics Inc. ยท Tests: CT-95 Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy NCT07504588Phase 213 sites๐Ÿ“ Fayetteville๐Ÿ“ Rogers๐Ÿ“ Springdale National Cancer Institute (NCI) ยท Tests: Anti-VEGF Monoclonal Antibody, Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) NCT03983226Phase 25 sites๐Ÿ“ Shanghai๐Ÿ“ Guangzhou๐Ÿ“ Hangzhou Shanghai Gynecologic Oncology Group ยท Tests: Surgery, carboplatin/taxane, carboplatin/gemcitabine, cisplatin/gemcitabine, liposome doxorubicin/carboplatin..., Nirapโ€ฆ Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer NCT03878849Phase 22 sites๐Ÿ“ Oklahoma City๐Ÿ“ Seattle Allarity Therapeutics ยท Tests: 2X-121, 2X-121 CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors NCT05410717Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance NCT05704621Phase 21 site๐Ÿ“ Seoul Korea University Guro Hospital ยท Tests: secondary cytoreductive surgery, chemotherapy Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy NCT07340164Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: Trastzumab Deruxtecan, Bevacizumab, Platinum Based Chemotherapy Feasibility of CALM in Patients With Ovarian Cancer NCT06459271NA1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Managing Cancer And Living Meaningfully (CALM) IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma NCT05112601Phase 2138 sites๐Ÿ“ Birmingham๐Ÿ“ Athens๐Ÿ“ Augusta National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging, Nivolumab SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer NCT06394492Phase 32 sites๐Ÿ“ Beijing๐Ÿ“ Hangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-A1921, Doxorubicin, Paclitaxel, Topotecan A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian Cancer NCT07714668Phase 21 site๐Ÿ“ Shanghai CSPC Megalith Biopharmaceutical Co.,Ltd. ยท Tests: SYS6041, bevacizumab, SYS6041, carboplatin, bevacizumab, paclitaxel, carboplatin, bevacizumab, SYS6041, enlonstobart, bโ€ฆ Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer. NCT05753826Phase 21 site๐Ÿ“ Fujian Fujian Cancer Hospital ยท Tests: Adebrelimab, Fuzuloparib Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery NCT04665635NA2 sites๐Ÿ“ Adana๐Ÿ“ Adana Cukurova University ยท Tests: Rectosigmoid resection Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer NCT07667192n/a1 site๐Ÿ“ Zamoล›ฤ‡ Affidea Nu-med Center of Oncological DIagnostics and Therapy ยท Tests: Reirradiation, Total Ablative Strategy Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer NCT07171528Phase 21 site๐Ÿ“ Goyang-si National Cancer Center, Korea ยท Tests: Secondary Cytoreductive Surgery SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma NCT05568680Phase 15 sites๐Ÿ“ Tampa๐Ÿ“ Westwood๐Ÿ“ Philadelphia Verismo Therapeutics ยท Tests: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer NCT06791460Phase 2, Phase 31 site๐Ÿ“ Shanghai Obstetrics & Gynecology Hospital of Fudan University ยท Tests: Pegylated liposomal doxorubicin plus adebrelimab with mirabegron, Pegylated liposomal doxorubicin plus adebrelimab APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST NCT06687070Phase 11 site๐Ÿ“ Guangzhou Ascentage Pharma Group Inc. ยท Tests: APG -2449, PLD APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion NCT04919629Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Bevacizumab, Biopsy, Biospecimen Collection, Pegcetacoplan, Pembrolizumab A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors NCT06515613Phase 115 sites๐Ÿ“ Little Rock๐Ÿ“ Beverly Hills๐Ÿ“ Denver Context Therapeutics Inc. ยท Tests: CTIM-76 Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer NCT06040970Phase 1, Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Sacituzumab, Cisplatin Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer NCT04921527Phase 31 site๐Ÿ“ Shanghai Chipscreen Biosciences, Ltd. ยท Tests: chiauranib, Placebo, Paclitaxel A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer NCT06710288Phase 22 sites๐Ÿ“ El Segundo๐Ÿ“ Newport Beach ImmunityBio, Inc. ยท Tests: Gemcitabine, N-803, M-CENK
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy